12-51591343-TCGC-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP6
The NM_001330260.2(SCN8A):c.-61_-59delCGC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000281 in 3,554 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: not found (cov: 30)
Exomes 𝑓: 0.00028 ( 0 hom. )
Consequence
SCN8A
NM_001330260.2 5_prime_UTR
NM_001330260.2 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.597
Genes affected
SCN8A (HGNC:10596): (sodium voltage-gated channel alpha subunit 8) This gene encodes a member of the sodium channel alpha subunit gene family. The encoded protein forms the ion pore region of the voltage-gated sodium channel. This protein is essential for the rapid membrane depolarization that occurs during the formation of the action potential in excitable neurons. Mutations in this gene are associated with cognitive disability, pancerebellar atrophy and ataxia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant 12-51591343-TCGC-T is Benign according to our data. Variant chr12-51591343-TCGC-T is described in ClinVar as [Likely_benign]. Clinvar id is 3029905.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN8A | NM_001330260.2 | c.-61_-59delCGC | 5_prime_UTR_variant | 1/27 | ENST00000627620.5 | NP_001317189.1 | ||
SCN8A | NM_014191.4 | c.-61_-59delCGC | 5_prime_UTR_variant | 1/27 | ENST00000354534.11 | NP_055006.1 | ||
SCN8A | NM_001177984.3 | c.-61_-59delCGC | 5_prime_UTR_variant | 1/26 | NP_001171455.1 | |||
SCN8A | NM_001369788.1 | c.-61_-59delCGC | 5_prime_UTR_variant | 1/26 | NP_001356717.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD3 genomes
Cov.:
30
GnomAD4 exome AF: 0.000281 AC: 1AN: 3554Hom.: 0 AF XY: 0.000398 AC XY: 1AN XY: 2512
GnomAD4 exome
AF:
AC:
1
AN:
3554
Hom.:
AF XY:
AC XY:
1
AN XY:
2512
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 30
GnomAD4 genome
Cov.:
30
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
SCN8A-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 19, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at